ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Evelyn1
|
612 |
278K |
3 |
00:18 |
00:18 |
ASX - By Stock
|
612
|
278K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Evelyn1
|
3.0K |
760K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
3.0K
|
760K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
10K
|
4.8M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
Evelyn1
|
187 |
74K |
41 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
187
|
74K
|
41
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Re:
Capital gains tax
|
|
Evelyn1
|
24 |
11K |
3 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
11K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
15 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Evelyn1
|
612 |
278K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
612
|
278K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Evelyn1
|
612 |
278K |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
612
|
278K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Evelyn1
|
231 |
121K |
16 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
231
|
121K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
10K
|
4.8M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
10K
|
4.8M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
0 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
10K
|
4.8M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
2 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
10K
|
4.8M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
14 |
24/12/23 |
24/12/23 |
ASX - By Stock
|
10K
|
4.8M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Psychiatric Indications
|
|
Evelyn1
|
16 |
7.5K |
11 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
16
|
7.5K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
Evelyn1
|
210 |
89K |
6 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
89K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
2 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
10K
|
4.8M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Evelyn1
|
1.1K |
572K |
17 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
1.1K
|
572K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
10K
|
4.8M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Evelyn1
|
677 |
324K |
3 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
677
|
324K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Evelyn1
|
677 |
324K |
4 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
677
|
324K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
5 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
10K
|
4.8M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren reports 2023 half-year profit after tax of $48m
|
|
Evelyn1
|
45 |
21K |
7 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
45
|
21K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Evelyn1
|
677 |
324K |
5 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
677
|
324K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
4 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
10K
|
4.8M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
1 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
10K
|
4.8M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
1 |
22/07/23 |
22/07/23 |
ASX - By Stock
|
10K
|
4.8M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
0 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
10K
|
4.8M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor web conference presentation, 14 July 2023
|
|
Evelyn1
|
35 |
14K |
15 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
35
|
14K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Evelyn1
|
677 |
324K |
0 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
677
|
324K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Evelyn1
|
677 |
324K |
2 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
677
|
324K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Evelyn1
|
3.0K |
760K |
0 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
3.0K
|
760K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Is Nova Eye Developing a NEW MIGS Device??
|
|
Evelyn1
|
23 |
6.0K |
2 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
23
|
6.0K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Evelyn1
|
3.0K |
760K |
2 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
3.0K
|
760K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Evelyn1
|
3.0K |
760K |
1 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
3.0K
|
760K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Evelyn1
|
3.0K |
760K |
2 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
3.0K
|
760K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Wilsons target $18.29 and summary
|
|
Evelyn1
|
65 |
35K |
6 |
22/04/23 |
22/04/23 |
ASX - By Stock
|
65
|
35K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Evelyn1
|
10K |
4.8M |
0 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
10K
|
4.8M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
The Steyne party has started
|
|
Evelyn1
|
16 |
6.7K |
4 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
16
|
6.7K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Guess Monday's NEU Closing Price
|
|
Evelyn1
|
48 |
16K |
3 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
48
|
16K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Good Luck and Thanks to All
|
|
Evelyn1
|
21 |
11K |
5 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
21
|
11K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
FDA Approval
|
|
Evelyn1
|
116 |
51K |
5 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
116
|
51K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Congratulations !!!
|
|
Evelyn1
|
24 |
9.7K |
14 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
24
|
9.7K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Opening & Close Predictions - Monday 13.03.23
|
|
Evelyn1
|
9 |
3.7K |
5 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
9
|
3.7K
|
5
|
|